| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |